Skip to content

Federal at other companies

TFX
TeleflexTFX
$8.4M-17.1%
PDE
Pro-Dex, Inc.PDEX
$528.5K+41.6%
UFP Technologies logo
UFP TechnologiesUFPT
$836.75K-51.1%
Baxter International logo
Baxter InternationalBAX
$29.5M+521%
CorMedix logo
CorMedixCRMD
$680.25K
Medline, Inc.
 logo
Medline, Inc. MDLN

Other financials

Income statement

See full
Revenue$8.7M-10.2%
Gross profit$5.3M-4.6%
Operating income$2.6M-18.6%
Net income$2.6M-14.4%
EPS (diluted)$0.82-10.9%

Balance sheet

See full
Cash & equivalents$87.4M+4.9%
Total debt$210.0K
Total equity$120.4M+2.8%
Total assets$124.4M+1.5%

Cash flow

See full
Operating cash flow$3.1M-30.4%
CapEx$130.0K-29.3%
Free cash flow$3.0M-30.4%

Valuation

See full
Market cap$219.63M+26.4%
Enterprise value$132.44M+42.5%
P/E20.3×+6.4×
P/S5.9×+1.4×

Profitability

See full
Gross margin57.9%-0.4pp
Operating margin28.8%-3.9pp
Net margin28.9%-4.1pp
FCF margin34.7%0.0pp

Returns & leverage

See full
Return on equity9.1%-1.4pp
Debt / equity
Current ratio28.6×+6.3×

Where this comes from

Reported directly by Utah Medical Products in its filing.

Tagged under the XBRL concept us-gaap:CurrentFederalTaxExpenseBenefit.

The official record: Utah Medical Products’s 10-K, filed March 27, 2026, on SEC EDGAR. View the filing →

Ask your AI about Utah Medical Products's federal.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Utah Medical Products's federal?
Utah Medical Products (UTMD) reported federal of $661.25K in Q4 2025.
How has Utah Medical Products's federal changed year-over-year?
Utah Medical Products's federal increased by 17.6% year-over-year, from $562.5K to $661.25K.
What is the long-term trend for Utah Medical Products's federal?
Over 2 years (2023 to 2025), Utah Medical Products's federal has grown at a 7.3% compound annual growth rate (CAGR), from $2.3M to $2.65M.
What does federal mean?
This metric measures the total current income tax expense or benefit payable to the national government based on taxable income for the period. It reflects the immediate cash tax obligation arising from domestic operations before accounting for deferred tax items. It is a key component in assessing the company's overall effective tax burden at the federal level.